McMillan Office’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
McMillan Office's MDT Position: Q2 2026 in Review
McMillan Office reduced its Medtronic (MDT) stake by 1.1% in Q2 2026, selling an estimated $26.2K and leaving 28,222 shares worth $2.21M. The position accounts for 0.25% of the portfolio, ranked #52.
McMillan Office first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.77M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- McMillan Office held 28,222 shares of Medtronic worth $2.21M as of Q2 2026.
- McMillan Office sold 325 Medtronic shares in Q2 2026, an estimated $26.2K.
- Medtronic made up 0.25% of McMillan Office's portfolio in Q2 2026, its #52 holding.
- McMillan Office first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
- McMillan Office's Medtronic position peaked at $2.77M in Q4 2025.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.